Graham Strachan
Voorzitter bij Ontario Mental Health Research Foundation
Profiel
Graham Strachan is the founder of Allelix Biopharmaceuticals, Inc. founded in 1981.
He is currently the Chairman at Ontario Mental Health Research Foundation, Hepoxagen Biopharmaceuticals, Cita NeuroPharmaceuticals, Inc., NIR, Inc., and Principal at GLS Business Development, Inc. He has formerly held positions as Chairman at Aptose Biosciences, Inc. and National Center for Biotechnology Information, Director at VIVUS, Inc., Arius Research, Inc., and IBEX Technologies, Inc., Independent Director at ProMIS Neurosciences, Inc., and Director at Millenium Biologix, Inc. He was also the President of Biotechnology Innovation Organization.
Mr. Strachan received his undergraduate and graduate degrees from the University of Glasgow.
Actieve functies van Graham Strachan
| Bedrijven | Functie | Begin |
|---|---|---|
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Directeur/Bestuurslid | - |
| Ontario Mental Health Research Foundation | Voorzitter | - |
| GLS Business Development, Inc. | Corporate Officer/Principal | 01-09-1999 |
| NIR, Inc. | Directeur/Bestuurslid | - |
| Hepoxagen Biopharmaceuticals | Voorzitter | 23-07-2009 |
Eerdere bekende functies van Graham Strachan
| Bedrijven | Functie | Einde |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Directeur/Bestuurslid | 13-10-2010 |
| VIVUS, INC. | Directeur/Bestuurslid | 27-04-2010 |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Directeur/Bestuurslid | 24-09-2008 |
| Allelix Biopharmaceuticals, Inc. | Oprichter | 01-01-1999 |
| ░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Graham Strachan
| University of Glasgow | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 12 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Cita NeuroPharmaceuticals, Inc.
Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Health Technology |
IBEX Technologies, Inc.
 IBEX Technologies, Inc. Medical SpecialtiesHealth Technology IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada. | Health Technology |
| Ontario Mental Health Research Foundation | |
| GLS Business Development, Inc. | |
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Health Technology |
| Millenium Biologix, Inc. | Commercial Services |
| NIR, Inc. | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
| Hepoxagen Biopharmaceuticals | |
| Allelix Biopharmaceuticals, Inc. | Health Technology |
| National Center for Biotechnology Information | Government |